Literature DB >> 27376894

SYBR Green II Dye-Based Real-Time Assay for Measuring Inhibitor Activity Against HIV-1 Reverse Transcriptase.

Chakradhar Kokkula1,2, Navaneethan Palanisamy1,3, Malin Ericstam1, Johan Lennerstrand4.   

Abstract

There are arrays of in vitro assays to quantify the activity of HIV-1 reverse transcriptase (HIV-1 RT). These assays utilize either chemically customized/labelled nucleotides, or TaqMan probes, or radiolabeled nucleotides/primers. Although several real-time PCR assays exist commercially for measuring the RT activity, which are usually used for quantifying the viral titres, these assays are not optimized for measuring the inhibitory concentrations (IC50) of HIV-1 RT inhibitors. Moreover, a recently established inorganic pyrophosphate-coupled enzyme assay cannot be employed for studying nonphosphorylated nucleoside reverse transcriptase inhibitors (NRTIs). In the present study, we have developed a novel one-step assay with native nucleotide substrates and SYBR Green II dye to determine IC50 values of triphosphorylated NRTIs against HIV-1 RT. Using exact batches of wild-type and mutant RT, and triphosphorylated NRTIs, we showed that our method gave IC50 values for inhibitors similar to that of an earlier published colorimetric assay with BrdUTP substrate (CABS). Our assay should be suitable for high-throughput screening of antiretroviral drugs and could also be suitable for studying drug resistance profiles. Additionally, we also used our assay to study inhibition by AZT in its nonphosphorylated form by supplementing the reaction mixture with necessary kinases and ATP.

Entities:  

Keywords:  HIV-1 reverse transcriptase (HIV-1 RT); IC50 concentrations; NRTIs; Resistance; SYBR Green II dye

Mesh:

Substances:

Year:  2016        PMID: 27376894     DOI: 10.1007/s12033-016-9961-y

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  27 in total

Review 1.  Resistance to enfuvirtide, the first HIV fusion inhibitor.

Authors:  Michael L Greenberg; Nick Cammack
Journal:  J Antimicrob Chemother       Date:  2004-07-01       Impact factor: 5.790

2.  A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening.

Authors:  Chang Zhang; Yang Wu; Yuna Sun; Chuan Hong; Kehui Xiang; Yu Guo; Mark Bartlam; Zhiyong Lou
Journal:  Protein Cell       Date:  2010-02-24       Impact factor: 14.870

3.  Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus.

Authors:  M H Lee; K Sano; F E Morales; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

4.  A sensitive non-isotopic assay specific for HIV-1 associated reverse transcriptase.

Authors:  T Porstmann; K Meissner; R Glaser; S H Döpel; G Sydow
Journal:  J Virol Methods       Date:  1991 Feb-Mar       Impact factor: 2.014

5.  Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

Authors:  A Hizi; R Tal; M Shaharabany; S Loya
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

6.  Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.

Authors:  D Arion; N Kaushik; S McCormick; G Borkow; M A Parniak
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

7.  A method for combined immunoaffinity purification and assay of HIV-1 reverse transcriptase activity useful for crude samples.

Authors:  J Lennerstrand; A S Rytting; C Orvell; J S Gronowitz; C F Kallander
Journal:  Anal Biochem       Date:  1996-03-15       Impact factor: 3.365

8.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay.

Authors:  T Urabe; K Sano; T Nakano; F Odawara; M H Lee; T Otake; S Okubo; M Hayami; H Misaki; M Baba
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

10.  Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.

Authors:  Valérie Goldschmidt; Joël Didierjean; Bernard Ehresmann; Chantal Ehresmann; Catherine Isel; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2006-01-03       Impact factor: 16.971

View more
  2 in total

1.  HIV pre-exposure prophylaxis adherence test using reverse transcription isothermal amplification inhibition assay.

Authors:  Jane Y Zhang; Yu Zhang; Andrew T Bender; Benjamin P Sullivan; Ayokunle O Olanrewaju; Lorraine Lillis; David Boyle; Paul K Drain; Jonathan D Posner
Journal:  Anal Methods       Date:  2022-03-31       Impact factor: 3.532

2.  Enzymatic Assay for Rapid Measurement of Antiretroviral Drug Levels.

Authors:  Ayokunle O Olanrewaju; Benjamin P Sullivan; Jane Y Zhang; Andrew T Bender; Derin Sevenler; Tiffany J Lo; Marta Fernandez-Suarez; Paul K Drain; Jonathan D Posner
Journal:  ACS Sens       Date:  2020-04-15       Impact factor: 9.618

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.